Thromboangiitis obliterans: Difference between revisions
Line 19: | Line 19: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Chronic PAD | |||
**Atherosclerosis Obliterans | |||
*Acute PAD | |||
**Atheroembolism (AKA Blue Toe Syndrome) | |||
**Arterial embolism | |||
**Arterial thrombosis | |||
*Vasospastic Disorders | |||
**Raynaud’s Disease | |||
**Primary Erythromelalgia | |||
==Evaluation== | ==Evaluation== |
Revision as of 16:01, 6 February 2017
Background
- AKA Thromboangiitis Obliterates
Pathophysiology
- Idiopathic inflammatory occlusive disease of the hands and feet
- Exact pathogenesis unknown
Risk Factors
- Male, tobacco, Middle Eastern
- Virtually all patients are smokers
Clinical Features
- Red, tender nodules over peripheral arteries
- +/- diminished pulses
- In-step claudication
- Hand claudication
- Often bilateral & symmetrical
- May lead to ulceration
Differential Diagnosis
- Chronic PAD
- Atherosclerosis Obliterans
- Acute PAD
- Atheroembolism (AKA Blue Toe Syndrome)
- Arterial embolism
- Arterial thrombosis
- Vasospastic Disorders
- Raynaud’s Disease
- Primary Erythromelalgia
Evaluation
- Clinical criteria for Dx (noninvasive testing not necessary)
- History of smoking
- Onset prior to <50 y/o
- Absence of atherosclerotic risk factors
- Upper limb involvement
- Infrapopliteal arterial occlusive lesions
Management
- Abstinence from tobacco
- Early symptoms w/o threatened tissue loss: outpatient vascular
- Advanced disease: intra-arterial or intravenous PGE1, ASA, Heparin, arterial reconstruction, sympathectomy